These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4333776)

  • 61. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
    [No Abstract]   [Full Text] [Related]  

  • 62. [On the effect of xanthinol nicotinate on the biosynthesis of oxidized pyridine nucleotides in the rat liver. A study on normal animals and liver damaged animals].
    Brenner G
    Arzneimittelforschung; 1968 Sep; 18(9):1153-5. PubMed ID: 4387884
    [No Abstract]   [Full Text] [Related]  

  • 63. [Phosphoribosyl pyrophosphate and its metabolic enzymes in the erythrocytes in certain forms of anemia].
    Blinov MN; Kamyshentsev MV; Luganova IS; Filanovskaia LI; Filippova VN
    Vopr Med Khim; 1976; 22(4):456-62. PubMed ID: 194412
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of the GTPase activity of transducin by an NAD+:arginine ADP-ribosyltransferase from turkey erythrocytes.
    Watkins PA; Kanaho Y; Moss J
    Biochem J; 1987 Dec; 248(3):749-54. PubMed ID: 2829839
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oxygen poisoning of NAD biosynthesis: a proposed site of cellular oxygen toxicity.
    Brown O; Yein F; Boehme D; Foudin L; Song CS
    Biochem Biophys Res Commun; 1979 Dec; 91(3):982-90. PubMed ID: 230838
    [No Abstract]   [Full Text] [Related]  

  • 66. [Advances in hematology. Blood platelets and anti-inflammatory agents].
    Pazdur J
    Pol Arch Med Wewn; 1970 Nov; 45(5):715-7. PubMed ID: 5488170
    [No Abstract]   [Full Text] [Related]  

  • 67. Orotate phosphoribosyl transferase and orotidylic acid decarboxylase activities in liver and Morris hepatomas.
    Hoffman DH; Sweeney MJ
    Cancer Res; 1973 May; 33(5):1109-12. PubMed ID: 4349934
    [No Abstract]   [Full Text] [Related]  

  • 68. Hypoxanthine-guanine phosphoribosyltransferase deficiency and erythrocyte synthesis of pyridine coenzymes.
    Micheli V; Sestini S; Rocchigiani M; Jacomelli G; Manzoni F; Peruzzi L; Gathof BS; Zammarchi E; Pompucci G
    Life Sci; 1999; 64(26):2479-87. PubMed ID: 10403507
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibitors of NAD
    Ghanem MS; Caffa I; Monacelli F; Nencioni A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396769
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeting NAD
    Yong J; Cai S; Zeng Z
    Front Immunol; 2023; 14():1269896. PubMed ID: 38116009
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators.
    Baldassarri C; Giorgioni G; Piergentili A; Quaglia W; Fontana S; Mammoli V; Minazzato G; Marangoni E; Gasparrini M; Sorci L; Raffaelli N; Cappellacci L; Petrelli R; Del Bello F
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259338
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase.
    Minazzato G; Marangoni E; Fortunato C; Petrelli R; Cappellacci L; Del Bello F; Sorci L; Gasparrini M; Piacente F; Bruzzone S; Raffaelli N
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770640
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors.
    Franco J; Piacente F; Walter M; Fratta S; Ghanem M; Benzi A; Caffa I; Kurkin AV; Altieri A; Herr P; Martínez-Bailén M; Robina I; Bruzzone S; Nencioni A; Del Rio A
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890155
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery.
    Ghanem MS; Caffa I; Del Rio A; Franco J; Parenti MD; Monacelli F; Cea M; Khalifa A; Nahimana A; Duchosal MA; Ravera S; Bertola N; Bruzzone S; Nencioni A; Piacente F
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890147
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Advances in NAD-Lowering Agents for Cancer Treatment.
    Ghanem MS; Monacelli F; Nencioni A
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068917
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Small Molecule Regulators Targeting NAD
    Curry A; White D; Cen Y
    Curr Med Chem; 2022; 29(10):1718-1738. PubMed ID: 34060996
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prostaglandins and renal NaCl excretion in healthy human subjects: effects of prostaglandin synthesis inhibition with indomethacin.
    Düsing R; Kipnowski J; Kramer HJ
    Klin Wochenschr; 1982 Oct; 60(19):1229-33. PubMed ID: 7144060
    [No Abstract]   [Full Text] [Related]  

  • 78. Inhibition of nicotinate phosphoribosyl transferase by nonsteroidal anti-inflammatory drugs: a possible mechanism of action.
    Gaut ZN; Solomon HM
    J Pharm Sci; 1971 Dec; 60(12):1887-8. PubMed ID: 4333776
    [No Abstract]   [Full Text] [Related]  

  • 79. Inhibition of 7- 14 C-nicotinic acid metabolism in the human blood platelet by anti-inflammatory drugs.
    Gaut ZN; Solomon HM
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):547-52. PubMed ID: 4400175
    [No Abstract]   [Full Text] [Related]  

  • 80. Inhibition of quinolinate phosphoribosyl transferase by pyridine analogs of quinolinic acid.
    Kalikin L; Calvo KC
    Biochem Biophys Res Commun; 1988 Apr; 152(2):559-64. PubMed ID: 2452632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.